Callan Capital, LLC Incyte Corp Transaction History
Callan Capital, LLC
- $1.36 Billion
- Q4 2024
A detailed history of Callan Capital, LLC transactions in Incyte Corp stock. As of the latest transaction made, Callan Capital, LLC holds 2,929 shares of INCY stock, worth $211,210. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,929
Previous 3,129
6.39%
Holding current value
$211,210
Previous $206,000
1.94%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding INCY
# of Institutions
706Shares Held
189MCall Options Held
909KPut Options Held
489K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.22 Billion23.54% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.54 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.6MShares$1.41 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.9MShares$1.08 Billion0.64% of portfolio
-
State Street Corp Boston, MA10MShares$723 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $16B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...